Luis Lara-Mejia (Luis Lara-Mejía)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Advanced Non Small Cell Lung Cancer

Combination Therapy

Top Venues

Future oncology (London, England)

Thoracic cancer

Instituto Nacional de Cancerología

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto Nacional de Cancerología Mar 01 2020

Mexico

MD :: Thoracic Oncology Unit

Publications

Alejandro Avilés-Salas, Diana Flores-Estrada, Luis Lara-Mejia, Rodrigo Catalán, Graciela Cruz-Rico, Mario Orozco-Morales, David Heredia, Laura Bolaño-Guerra, Pamela Denisse Soberanis-Piña, Edgar Varela-Santoyo, Andrés F Cardona, Arrieta Oscar
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer. Thoracic cancer 13 (23) (2022)
Arrieta Oscar, Luis Lara-Mejia, Elysse Bautista-GonzÁlez, David Heredia, Jenny G Turcott, Feliciano Barrón, Maritza Ramos-Ramírez, Luis Cabrera-Miranda, Miguel Ángel Salinas Padilla, Mercedes Aguerreberre, Andrés Felipe Cardona, Christian D Rolfo, Marisol Arroyo-HernÁndez, Enrique Soto Pérez de Celis, Renata Baéz-Saldaña
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies. The oncologist 26 (12) (2021)
David Heredia, Feliciano Barrón, Andrés F Cardona, Saul Campos, Jerónimo Rafael Rodríguez-Cid, Luis Martinez-Barrera, Jorge Alatorre, Miguel Ángel Salinas, Luis Lara-Mejia, Diana Flores-Estrada, Arrieta Oscar
Brigatinib in ALK-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP). Future oncology (London, England) 17 (2) (2020)